SCPC Praises CMS Recognition of Unique Characteristics of LTC Patient Population
WASHINGTON, April 10, 2018 — Commenting broadly on the Center for Medicare and Medicaid Services’ (CMS) Final Rule modifying Medicare Part D regulations as well as the Final Part D Call Letter for 2019, the Senior Care Pharmacy Coalition (SCPC) praised the agency for its recognition of the unique needs of long-term care (LTC) patients, and the stringent safeguards employed by LTC pharmacies in the context of opioid control and distribution.
“We are particularly gratified that the agency modified opioid control provisions based on the unique characteristics of long-term care patients and the heightened controls that long-term care pharmacies provide,” stated Alan G. Rosenbloom, President and CEO of the SCPC, the only Washington-based organization exclusively representing the interests of long-term care (LTC) pharmacies and the patients they serve.
Rosenbloom said that while other provisions do not appropriately distinguish between long-term care settings and community settings — which threaten continuity of care for Medicare beneficiaries — the overall changes help set the stage for a subsequent policy discussion surrounding the need to establish a specific federal definition of LTC pharmacies.
“SCPC is pleased that the regulatory community, as well as Congress, is increasingly aware of the significant structural and operational differences between LTC pharmacies and retail pharmacies,” Rosenbloom continued. “It is important to specifically codify these differences for the benefit of patients, the broader health community and taxpayers. We look forward to sustaining this policy discussion thorough 2018.”
The SCPC President and CEO also said the LTC pharmacy advocacy group appreciates CMS Administrator Seema Verma’s consideration of inappropriate fees and other payment adjustments that Part D Plans and their affiliated pharmacy benefits managers (PBMs) unjustifiability impose on long-term care pharmacies.
“These practices increase drug costs for beneficiaries and the Medicare program, and we look forward to the Trump Administration’s anticipated plan to respond to high drug prices.”
###
The SCPC is the national association for independent LTC pharmacies. Our member pharmacies provide care and services to patients in LTC facilities across the country occupying approximately 750,000 beds. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
SCPC Calls for Immediate Congressional Action to Fix Broken LTC Pharmacy Payment Model as More Drugs Become Subject to Mandatory Medicare Price Negotiations
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
SCPC Praises FTC for Report Highlighting Egregious PBM Abuses; Encourages Congress and New Administration to Make PBM Reform an Immediate Priority in 2025
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
Seniors in Long-Term Care Could Lose Access to Essential LTC Pharmacy Services Absent Action from Congress
A new study from the Senior Care Pharmacy Coalition (SCPC), the nation’s leading voice for long-term care (LTC) pharmacies, performed by CLA (CliftonLarsonAllen LLP) and with input from ATI Advisory details the significant financial impact Medicare drug price negotiations will have on LTC pharmacies that provide essential, government required services to more than two million seniors and others in long-term care.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.